← Eichor
Condition: Liposarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Liposarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
Phase 1 · 1 location(s) · University of Washington · NCT06025747Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06198296Genomic Risk in Retroperitoneal Sarcoma
Phase N/A · 1 location(s) · Fox Chase Cancer Center · NCT06436846A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiat
Phase 1 · 2 location(s) · Memorial Sloan Kettering Cancer Center · NCT05607095Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/Phase 2 · 22 location(s) · Milton S. Hershey Medical Center · NCT06541262IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
Phase 2 · 1 location(s) · Fudan University · NCT06849986Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Phase 1/Phase 2 · 17 location(s) · Grupo Espanol de Investigacion en Sarcomas · NCT02275286Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Lamassu Bio Inc · NCT06578624Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · 257 location(s) · National Cancer Institute (NCI) · NCT06422806Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tis
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06498648Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
NA · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04224064Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Adv
Phase 1 · 16 location(s) · National Cancer Institute (NCI) · NCT05711615Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Phase 2 · 2 location(s) · Oslo University Hospital · NCT07173972Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06957431NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C
EARLY_Phase 1 · 1 location(s) · Seth Pollack · NCT07261657STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants
Phase 1/Phase 2 · 9 location(s) · STORM Therapeutics LTD · NCT06975293Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT07148050Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tu
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04715191START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1 · 7 location(s) · Valo Therapeutics Oy · NCT05492682A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid
Phase 1/Phase 2 · 16 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05944224A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Phase 1 · 10 location(s) · Epkin · NCT06789172International Prospective Registry on Local Treatment Approaches in MLS
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT04699292A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Phase 3 · 13 location(s) · Rezolute · NCT06881992A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06843967Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06083883Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Phase 3 · 169 location(s) · European Organisation for Research and Treatment of Cancer - · NCT04031677A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07089992A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Phase 2 · 4 location(s) · Lund University Hospital · NCT06389799Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
Phase 2 · 4 location(s) · Oslo University Hospital · NCT07169344
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.